|
|
Beyond ganglion cells: Novel foveal avascular zone features in MS with implications for vision loss |
| 1R01EY033475-01A1 |
|
NEI |
2022 |
|
|
Identification of a novel pathway that regulates optic nerve myelination and remyelination |
| 3R00EY029330-05S1 |
|
NEI |
2022 |
|
|
Developing Remyelination Strategies for Demyelinating Optic Neuropathies Using Human Pluripotent Stem Cells |
| 4R00EY029011-03 |
|
NEI |
2022 |
|
|
Molecular Mechanisms of Diabetic Retinal Ganglion Cell Dysfunction and Neurovascular Crosstalk in Early Diabetic Retinopathy |
| 5K08EY029766-04 |
|
NEI |
2022 |
|
|
Identification of a novel pathway that regulates optic nerve myelination and remyelination |
| 5R00EY029330-05 |
|
NEI |
2022 |
|
|
Defining the Chemical Perturbome of Neural Development and Activity |
| 1DP2NS132107-01 |
|
NINDS |
2022 |
|
|
Chemical Control of Misfolded Protein Fate |
| 1DP2NS132610-01 |
|
NINDS |
2022 |
|
|
Parkinsons disease therapies targeting GUCY2C |
| 1F30NS125921-01A1 |
|
NINDS |
2022 |
|
|
Pathogenic mechanism of intrathecally synthesized immunoglobulins in a mouse model of progressive multiple sclerosis |
| 1F31NS118955-01A1 |
|
NINDS |
2022 |
|
|
Neural Mechanisms Supporting Implicit and Explicit Sensorimotor Learning |
| 1F31NS120448-01A1 |
|
NINDS |
2022 |